Biosyent Stock Performance
| BIOYF Stock | USD 10.10 0.74 7.91% |
On a scale of 0 to 100, Biosyent holds a performance score of 13. The firm shows a Beta (market volatility) of -0.49, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Biosyent are expected to decrease at a much lower rate. During the bear market, Biosyent is likely to outperform the market. Please check Biosyent's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Biosyent's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Biosyent are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Biosyent reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 20.3 M | |
| Total Cashflows From Investing Activities | -4.8 M |
Biosyent |
Biosyent Relative Risk vs. Return Landscape
If you would invest 761.00 in Biosyent on November 12, 2025 and sell it today you would earn a total of 249.00 from holding Biosyent or generate 32.72% return on investment over 90 days. Biosyent is currently producing 0.5204% returns and takes up 3.1016% volatility of returns over 90 trading days. Put another way, 27% of traded pink sheets are less volatile than Biosyent, and 90% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Biosyent Target Price Odds to finish over Current Price
The tendency of Biosyent Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.10 | 90 days | 10.10 | nearly 4.48 |
Based on a normal probability distribution, the odds of Biosyent to move above the current price in 90 days from now is nearly 4.48 (This Biosyent probability density function shows the probability of Biosyent Pink Sheet to fall within a particular range of prices over 90 days) .
Biosyent Price Density |
| Price |
Predictive Modules for Biosyent
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biosyent. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biosyent's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biosyent Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biosyent is not an exception. The market had few large corrections towards the Biosyent's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biosyent, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biosyent within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.49 | |
β | Beta against Dow Jones | -0.49 | |
σ | Overall volatility | 0.76 | |
Ir | Information ratio | 0.12 |
Biosyent Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biosyent for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biosyent can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biosyent appears to be risky and price may revert if volatility continues | |
| About 41.0% of the company shares are held by company insiders |
Biosyent Fundamentals Growth
Biosyent Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Biosyent, and Biosyent fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biosyent Pink Sheet performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.29 % | |||
| Current Valuation | 45.49 M | |||
| Shares Outstanding | 12.1 M | |||
| Price To Earning | 23.21 X | |||
| Price To Book | 2.56 X | |||
| Price To Sales | 2.27 X | |||
| Revenue | 28.62 M | |||
| EBITDA | 8.92 M | |||
| Cash And Equivalents | 27.9 M | |||
| Cash Per Share | 2.28 X | |||
| Total Debt | 1.48 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 2.71 X | |||
| Cash Flow From Operations | 4.67 M | |||
| Earnings Per Share | 0.36 X | |||
| Total Asset | 37.17 M | |||
About Biosyent Performance
By analyzing Biosyent's fundamental ratios, stakeholders can gain valuable insights into Biosyent's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biosyent has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biosyent has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, Canada. Biosyent operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Biosyent performance evaluation
Checking the ongoing alerts about Biosyent for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Biosyent help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biosyent appears to be risky and price may revert if volatility continues | |
| About 41.0% of the company shares are held by company insiders |
- Analyzing Biosyent's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biosyent's stock is overvalued or undervalued compared to its peers.
- Examining Biosyent's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biosyent's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biosyent's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biosyent's pink sheet. These opinions can provide insight into Biosyent's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biosyent Pink Sheet analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |